Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems
暂无分享,去创建一个
E. Halm | Chyke A Doubeni | C. Rutter | Yingye Zheng | T. Levin | C. Klabunde | D. Corley | Jessica Chubak | B. Green | V. Quinn | A. Singal | A. Kamineni | J. Schottinger | A. Burnett-Hartman | Michael P. Garcia
[1] Jasmin A. Tiro,et al. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium , 2016, Journal of General Internal Medicine.
[2] Sarah E Lillie,et al. Organizational Predictors of Colonoscopy Follow-up for Positive Fecal Occult Blood Test Results: An Observational Study , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[3] S. Vernon,et al. Results of Nurse Navigator Follow-up After Positive Colorectal Cancer Screening Test: A Randomized Trial , 2014, The Journal of the American Board of Family Medicine.
[4] J. Zapka,et al. Follow-up to Abnormal Cancer Screening Tests: Considering the Multilevel Context of Care , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[5] Yingye Zheng,et al. The Colorectal Cancer Screening Process in Community Settings: A Conceptual Model for the Population-Based Research Optimizing Screening through Personalized Regimens Consortium , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[6] JL Krok,et al. Clinic Type and Patient Characteristics Affecting Time to Resolution After an Abnormal Cancer-Screening Exam , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[7] J. Le Breton,et al. Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test , 2013, British Journal of Cancer.
[8] Mack T. Ruffin,et al. What is lacking in current decision aids on cancer screening? , 2013, CA: a cancer journal for clinicians.
[9] E. Seiber,et al. The Ohio Patient Navigation Research Program: Does the American Cancer Society Patient Navigation Model Improve Time to Resolution in Patients with Abnormal Screening Tests? , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[10] C. von Wagner,et al. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme , 2012, British Journal of Cancer.
[11] K. Choi,et al. Adherence to follow‐up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004–2008 , 2012, Journal of gastroenterology and hepatology.
[12] S. Bolen,et al. Body Mass Index and Colon Cancer Screening: A Systematic Review and Meta-Analysis , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[13] M. Helfand,et al. Improving the Follow-Up of Positive Hemoccult Screening Tests: An Electronic Intervention , 2011, Journal of General Internal Medicine.
[14] L. Walter,et al. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up? , 2011, Archives of internal medicine.
[15] S. Ho,et al. Improving the Effectiveness of Fecal Occult Blood Testing in a Primary Care Clinic by Direct Colonoscopy Referral for Positive Tests , 2010, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.
[16] C Fraser,et al. Effect of Gender, Age and Deprivation on Key Performance Indicators in a Fobt-based Colorectal Screening Programme , 2010, Journal of medical screening.
[17] D. Almirall,et al. Time from Positive Screening Fecal Occult Blood Test to Colonoscopy and Risk of Neoplasia , 2009, Digestive Diseases and Sciences.
[18] M. Partin,et al. Timely follow-up of positive fecal occult blood tests strategies associated with improvement. , 2009, American journal of preventive medicine.
[19] Hardeep Singh,et al. Using a Multifaceted Approach to Improve the Follow-Up of Positive Fecal Occult Blood Test Results , 2009, The American Journal of Gastroenterology.
[20] Sandhya K. Rao,et al. Challenges in the Management of Positive Fecal Occult Blood Tests , 2009, Journal of General Internal Medicine.
[21] B. Turner,et al. Reasons Patients With a Positive Fecal Occult Blood Test Result Do Not Undergo Complete Diagnostic Evaluation , 2009, The Annals of Family Medicine.
[22] Bernadette Mazurek Melnyk,et al. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.
[23] E. Feuer,et al. Improvement in the Diagnostic Evaluation of a Positive Fecal Occult Blood Test in an Integrated Health Care Organization , 2008, Medical care.
[24] Perry J Pickhardt,et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * † , 2008, CA: a cancer journal for clinicians.
[25] Katherine S. Garman,et al. Colorectal Cancer Screening, Comorbidity, and Follow-up in Elderly Patients , 2006, The American journal of the medical sciences.
[26] D. Fisher,et al. Barriers to Full Colon Evaluation for a Positive Fecal Occult Blood Test , 2006, Cancer Epidemiology Biomarkers & Prevention.
[27] Timothy R Church,et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. , 2004, Journal of the National Cancer Institute.
[28] Terry Hyslop,et al. Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. , 2004, Preventive medicine.
[29] Laurence L. George,et al. The Statistical Analysis of Failure Time Data , 2003, Technometrics.
[30] W. Hauck,et al. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test , 2003, Journal of General Internal Medicine.
[31] B. Rosner,et al. Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood , 2001, American Journal of Gastroenterology.
[32] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[33] L. Rabeneck,et al. Endoscopic follow-up of positive fecal occult blood testing in the Ontario FOBT Project. , 2007, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[34] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.